A research collaboration led from the MRC CTU at UCL suggests that the anti-cancer effects of aspirin are mediated through suppression of platelet activation.
News
If you wish to view this page in your preferred RSS reader, you can access the RSS feed here.
ALASSCA trial in PIK3CA-mutated Colorectal Cancer
ALASSCA Trial Results – 2025 ASCO Gastrointestinal Cancer Symposium. The ALASCCA trial, recently presented at ASC0 2025, evaluated aspirin after colorectal cancer resection in patients whose tumou ...
Aspirin: Scientist crack how painkiller might stop cancers from spreading - BBC News
Link to the BBC News article Scientific journal reports that ‘Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity’ Findings in the paper published in Nature on 5 ...
Confirmed Changes to United States (US) guidance on taking daily aspirin to prevent heart disease and stroke
In October 2021 we reported that the United States (US) Preventive Services Task Force was considering making a number of changes to its guidance on taking a daily aspirin to prevent heart disease and ...
News and Resources